A few studies suggest that reduced circulating levels of specifically the HMW form of adiponectin is connected to development of obesity-associated metabolic disease and that higher-order adiponectin complexes protect from progress to T2D [61,62]. Here, ADIPOQ is linked to obesity disorder.